29706 Federal Register / Vol. 74, No. 119 / Tuesday, June 23, 2009 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Annual 

Estimates of Influenza Vaccine 

Effectiveness for Preventing 

Laboratory Confirmed Influenza in the 

United States, Funding Opportunity 

Announcement (FOA) IP08– 

00101SUPP10, Initial Review 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 1 p.m.–3 p.m., August 12, 

2009 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Annual Estimates of Influenza 

Vaccine Effectiveness for Preventing 

Laboratory Confirmed Influenza in the 

United States, FOA IP08–00101SUPP10.’’ 

For More Information Contact: Gregory 

Anderson, M.P.H., M.S., CDC, 1600 Clifton 

Road, NE., Mailstop E60, Atlanta, GA 30333, 

Telephone: (404) 498–2275. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: June 12, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–14658 Filed 6–22–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, NCI–ARRA 

P30 Biomedical Research Core Centers 

Review. 

Date: July 20–21, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel & 

Conference Center, Bethesda, MD 20852. 

Contact Person: Bratin K. Saha, PhD, 

Scientific Review Officer, Program 

Coordination and Referral Branch, Division 

of Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 8041, Bethesda, MD 20892. (301) 402– 

0371. sahab@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control; 93.701, ARRA Related 

Biomedical Research and Research Support 

Awards, National Institutes of Health, HHS). 

Dated: June 17, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–14699 Filed 6–22–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Human 

Genome Research Institute Special Emphasis 

Panel. RC2 Medical Sequencing. 

Date: July 15–16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott and 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Rudy O. Pozzatti, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Human Genome Research 

Institute, 5635 Fishers Lane, Suite 4076, MSC 

9306, Rockville, MD 20852. (301) 402–0838. 

pozzattr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: June 17, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–14698 Filed 6–22–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Notice Regarding Substance Abuse 

and Mental Health Services 

Administration’s National Registry of 

Evidence-Based Programs and 

Practices (NREPP): Open Submission 

Period for Fiscal Year 2010 

AGENCY: Substance Abuse and Mental 

Health Services Administration. 

ACTION: Notice regarding Substance 

Abuse and Mental Health Services 

Administration’s National Registry of 

Evidence-based Programs and Practices 

(NREPP): Open submission period for 

Fiscal Year 2010. 

SUMMARY: The Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) is committed to preventing 

the onset and reducing the progression 

of mental illness, substance abuse, and 

substance-related problems among all 

individuals. As part of this effort, 

SAMHSA has expanded and refined the 

agency’s National Registry of Evidencebased Programs and Practices (NREPP). 

Two previous notices announcing these 

changes have been published in the 

Federal Register (70 FR 50381, Aug. 26, 

2005; 71 FR 13133, Mar. 14, 2006). 

Since 2006, SAMHSA has held two 

open submission periods during which 

interventions could be submitted for 

potential review and inclusion on the 

NREPP Web site (71 FR 37590, June 30, 

2006; 72 FR 30814, June 4, 2007). This 

notice announces the open submission 

period for fiscal year 2010, explains 

Federal Register / Vol. 74, No. 119 / Tuesday, June 23, 2009 / Notices 29707 

how submissions will be screened and 

selected, and provides guidance on the 

submission process for individuals and 

organizations seeking to have an 

intervention reviewed and listed on the 

NREPP Web site. Potential applicants 

should be aware that this notice 

includes new information relating to the 

eligibility of interventions and the 

review process that supersedes guidance 

provided in earlier Federal Register 

notices. 

FOR FURTHER INFORMATION CONTACT: 

Kevin D. Hennessy, Ph.D., Science to 

Service Coordinator/SAMHSA, 1 Choke 

Cherry Road, Room 8–1017, Rockville, 

MD 20857, (240) 276–2234. 

Dated: June 16, 2009. 

Eric B. Broderick, 

Acting Administrator, SAMHSA Assistant 

Surgeon General. 

Substance Abuse and Mental Health 

Services Administration’s National 

Registry of Evidence-based Programs 

and Practices (NREPP): Open 

Submission Period for Fiscal Year 2010 

Background 

The Substance Abuse and Mental 

Health Services Administration’s 

(SAMHSA) National Registry of 

Evidence-based Programs and Practices 

(NREPP) is a voluntary rating system 

designed to provide the public with 

reliable information about interventions 

that promote mental health or prevent 

or treat mental illness, substance use 

disorders, or co-occurring disorders. 

Programs and practices that are 

accepted for inclusion in the registry 

undergo two independent review 

processes in which their (1) quality of 

research and (2) readiness for 

dissemination are evaluated and rated. 

The results of these reviews are 

published on the NREPP Web site 

(http://nrepp.samhsa.gov). 

It should be noted that inclusion in 

NREPP does not constitute endorsement 

of an intervention by SAMHSA. 

Moreover, since NREPP has not 

reviewed all interventions, the use of 

NREPP as an exclusive or exhaustive list 

of interventions is not appropriate. 

Policymakers and funders in particular 

are discouraged from limiting 

contracted providers and/or potential 

grantees to selecting only among NREPP 

interventions. 

This notice announces the next open 

submission period during which 

SAMHSA will consider and accept new 

applications for review, describes the 

minimum requirements and other 

considerations that will be used in 

screening and selecting interventions, 

and provides guidance on the 

submission process. 

Dates of Open Submission Period 

SAMHSA has established a 4-month 

period for receipt of NREPP submissions 

for fiscal year 2010 that will begin 

October 1, 2009, and end February 1, 

2010. Interventions submitted after 

February 1, 2010, will not be considered 

during this submission cycle. Program 

developers, researchers, and others 

interested in submitting an intervention 

should read this notice for information 

about current minimum requirements 

and examine the information provided 

on the NREPP Web site about the review 

process and review criteria (http:// 

nrepp.sarnhsa.gov/review.asp). The 

selection of interventions will take place 

after the closing of the open submission 

period, and applicants will be informed 

of their acceptance status at that time. 

The number of reviews conducted will 

depend on the availability of funds, 

with the final selection of interventions 

and the timing of reviews to be 

determined at the discretion of 

SAMHSA. 

In submitting an intervention, 

applicants understand that the results of 

NREPP reviews are considered public 

information and will be posted on the 

NREPP Web site. Once a review is 

completed, the applicant will be 

provided with a summary document 

(‘‘intervention summary’’) that presents 

ratings and descriptive information 

about the intervention. Applicants are 

encouraged to view examples of NREPP 

intervention summaries on the NREPP 

Web site to become familiar with the 

end product of the review process. 

Minimum Requirements 

To be considered for review, 

interventions must meet four minimum 

requirements: 

1. The intervention has produced one 

or more positive behavioral outcomes 

(p≤.O5) in mental health or substance 

use among individuals, communities, or 

populations. 

2. Evidence of these outcomes has 

been demonstrated in at least one study 

using an experimental or quasiexperimental design. Experimental 

designs require random assignment, a 

control or comparison group, and preand postintervention assessments. 

Quasi-experimental designs do not 

require random assignment but do 

require a comparison or control group 

and pre- and postintervention 

assessments; this category includes 

longitudinal/multiple time series 

designs with at least three 

preintervention or baseline 

measurements and at least three 

postintervention or follow-up 

measurements. 

3. The results of these studies have 

been published in a peer-reviewed 

journal or other publication or 

documented in a comprehensive 

evaluation report. Comprehensive 

evaluation reports must include a 

review of the literature, theoretical 

framework, purpose, methodology, 

findings/results, discussion, and 

conclusions. 

4. Implementation materials, training 

and support resources, and quality 

assurance procedures have been 

developed and are ready for use by the 

public. 

Applicants are required to provide 

documentation at the time of 

submission that demonstrates that the 

intervention meets these minimum 

requirements. Table 1 lists examples of 

appropriate supporting documentation. 

TABLE 1—DOCUMENTATION FOR DEMONSTRATING COMPLIANCE WITH MINIMUM REQUIREMENTS

Minimum requirement Documentation 

Quality of Research ................................. 1. Intervention has produced one or 

more positive behavioral outcomes 

(p. ≤ .05) in mental health or substance use among individuals, communities, or populations.

A list of significant behavioral outcomes that includes supporting citations for each outcome; and 

2. Evidence of these outcomes has 

been demonstrated in at least one 

study using an experimental or 

quasiexperimental design.

A full-text copy of each article/report cited in the list of outcomes. Other research articles, published or unpublished 

evaluation reports, grant final reports, and replication 

studies may be submitted as additional supporting documentation. 

29708 Federal Register / Vol. 74, No. 119 / Tuesday, June 23, 2009 / Notices 

TABLE 1—DOCUMENTATION FOR DEMONSTRATING COMPLIANCE WITH MINIMUM REQUIREMENTS—Continued 

Minimum requirement Documentation 

3. Results of these studies have been 

published in a peer-reviewed journal 

or other publication or documented in 

a comprehensive evaluation report.

Note: Abstracts or URLs to partial articles are regarded as 

incomplete and will not be considered. 

Readiness for Dissemination ................... 4. Implementation materials, training 

and support resources, and quality 

assurance procedures have been developed and are ready for use by the 

public.

Brief narrative description and list of available materials, resources, and systems to support implementation (e.g., 

treatment manuals, information for administrators, tested 

training curricula, mechanisms for ongoing supervision 

and consultation, protocols for gathering process and 

outcome data, ongoing monitoring of intervention fidelity, 

processes for gathering feedback). 

The following types of interventions 

are not eligible for review and should 

not be submitted to NREPP: 

1. Stand-alone pharmacologic 

treatments—The evidence base for 

pharmacologic treatments is reviewed 

and approved through the U.S. Food 

and Drug Administration (FDA). FDAapproved pharmacotherapy 

interventions (on label use) are 

considered for NREPP review only 

when combined with one or more 

behavioral or psychosocial treatments. 

2. Stand-alone smoking prevention 

and/or cessation interventions— 

Interventions to prevent or reduce 

tobacco use are eligible for NREPP 

review only when conducted as part of 

a program that also addresses the 

prevention or treatment of alcohol or 

other drugs of abuse. 

Selection of Interventions for Review 

All submissions meeting the 

minimum requirements will be 

considered eligible for review. The 

priority point system described in past 

Federal Register notices will no longer 

be used in the prioritization of 

submissions. In selecting interventions 

for review, SAMHSA may choose to 

give special consideration to 

interventions that meet one or more of 

the following conditions: 

• The original investigator(s) or an 

independent party has used the same 

protocol with an identical or similar 

target population, and/or has used a 

slightly modified protocol based on a 

slightly modified population, where 

results are consistent with positive 

findings from the original evaluation. 

• Implementation materials (e.g., 

program manuals, training guides, 

measurement instruments, 

implementation fidelity guides) are 

available to the public at no cost. 

• The intervention targets 

underserved populations (e.g., minority 

populations, elderly, young adults, and 

individuals who are incarcerated). The 

intervention contributes to a content 

area where there are currently limited 

evidence-based interventions. 

Interventions that are not selected for 

review may be resubmitted by the 

applicant in a future open submission 

period. 

Instructions for Submitting an 

Intervention 

To submit an intervention, 

individuals should send a written 

statement to NREPP expressing their 

interest along with documentation that 

demonstrates that the intervention 

meets the minimum requirements as 

described above. All submissions must 

be made either by a principal 

investigator (PI) who has conducted 

research on the intervention, a project 

director (PD) who has worked with an 

evaluator of the intervention, or a 

formally authorized delegate of the PI or 

PD. For information on where to submit 

materials, please call 1–866–436–7377. 

Electronic submissions are preferred, 

but materials may be sent to NREPP in 

hard copy via postal mail or fax. To be 

eligible for consideration, submissions 

must be received no later than 11:59 pm 

EST on February 1, 2010; those received 

before October 1, 2009, will be 

disregarded. 

If an intervention is accepted, the PI 

will be contacted and asked to submit 

additional documentation to be used in 

the review. This additional 

documentation includes full-text copies 

of all articles and reports that provide 

evidence of significant outcomes 

(p≤.O5) as well as 8 copies of selected 

dissemination materials in the format 

they are provided to the public (e.g., 

hard copies or electronic versions of 

manuals, training presentations, tools, 

quality assurance protocols; URLs for 

interactive Web-based resources). 

The PI is expected to serve as the 

main point of contact throughout the 

remainder of the review process, 

including approval of the final 

intervention summary that is developed 

by NREPP staff once the review has 

been completed. 

Contact Information 

Individuals who have questions about 

the information contained in this notice 

may write to NREPP staff at 

nrepp@samhsa.hhs.gov or call 1–866– 

436–7377. 

[FR Doc. E9–14621 Filed 6–22–09; 8:45 am] 

BILLING CODE 4160–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Recruitment of Sites for Assignment of 

Corps Personnel Obligated Under the 

National Health Service Corps 

Scholarship Program 

AGENCY: Health Resources and Services 

Administration, HHS. 

ACTION: General notice. 

SUMMARY: The Health Resources and 

Services Administration (HRSA) 

announces that the listing of entities, 

and their Health Professional Shortage 

Area (HPSA) scores, that will receive 

priority for the assignment of National 

Health Service Corps (NHSC) 

scholarship recipients (Corps Personnel, 

Corps members) during the period July 

1, 2009, through June 30, 2010, is posted 

on the NHSC Web site at http:// 

nhscjobs.hrsa.gov/. This list specifies 

which entities are eligible to receive 

assignment of Corps members who are 

participating in the NHSC Scholarship 

Program. A separate Federal Register 

Notice pertaining to sites eligible to 

receive NHSC Loan Repayment Program 

participants and non-obligated 

individuals was published on May 28, 

2009 (74 FR 25568). Please note that not 

all vacancies associated with sites on 

the list described below will be for 

Corps members, but could be for NHSC 

Scholarship Program participants